SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Laboratories informs about press release

28 Jun 2022 Evaluate

Dr. Reddy's Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F’.

The above information is a part of company’s filings submitted to BSE.


Dr. Reddys Labs. Share Price

1364.85 -11.45 (-0.83%)
30-Jun-2026 12:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1869.35
Dr. Reddys Labs. 1364.85
Cipla 1471.75
Zydus Lifesciences 1123.35
Lupin 2409.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: